World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
50
Citations
8666
World Ranking
5773
National Ranking
2544

Rosemarie M. Booze publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Rosemarie M. Booze sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 203 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Rosemarie M. Booze D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Rosemarie M. Booze sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 50 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Rosemarie M. Booze is affiliated with the University of South Carolina in the United States and has a research focus spanning neuroscience, immunology, and microbiology. Their scholarly output includes work on HIV research and treatment as the predominant topic, with additional interests in neuroinflammation and neurodegeneration mechanisms, tryptophan and brain disorders, primate behavior and ecology, neuroscience and neuropharmacology research, cell image analysis techniques, and mosquito-borne diseases and control.

Their most frequently published subfields of study include virology, neurology, cellular and molecular neuroscience, biological psychiatry, and social psychology. Booze's work has appeared consistently in several publication venues, including bioRxiv (Cold Spring Harbor Laboratory), Journal of Visualized Experiments, Journal of NeuroVirology, NeuroImmune Pharmacology and Therapeutics, and Cells.

Among their recent papers are:

  • "HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits" (2021, Cells)
  • "Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders" (2021, Viruses)
  • "HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History" (2020, Journal of Neuroimmune Pharmacology)
  • "Disruption of Mitochondrial-associated ER membranes by HIV-1 tat protein contributes to premature brain aging" (2022, CNS Neuroscience & Therapeutics)
  • "A Rat Model of EcoHIV Brain Infection" (2021, Journal of Visualized Experiments)

The frequent coauthors who have collaborated with Booze include Charles F. Mactutus, Kristen A. McLaurin, Steven B. Harrod, Hailong Li, and Jessica M. Illenberger. This network of collaboration aligns with their research focus on neuroimmune pharmacology and HIV-associated neurological disorders.

Rosemarie M. Booze's research demonstrates an interdisciplinary approach combining neurobiology, immunology, and virology, particularly addressing HIV-related neurocognitive issues. Their work also touches on advanced molecular neuroscience techniques and the neurobiological impacts of chronic drug abuse in the context of HIV.

In recognition of their contributions, Booze was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2011.

Best Publications

  • Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

    Alessandra Castegna;Michael Aksenov;Marina Aksenova;Visith Thongboonkerd

  • Molecular basis for interactions of HIV and drugs of abuse.

    Avi Nath;Kurt F. Hauser;Kurt F. Hauser;Valerie Wojna;Valerie Wojna;Rosemarie M. Booze;Rosemarie M. Booze

  • Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.

    R. Kaminski;R. Bella;C. Yin;J. Otte

  • Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia.

    Avindra Nath;Carol Anderson;Melina Jones;William Maragos

  • Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum

    Arvind K. Bansal;Charles F. Mactutus;Avindra Nath;William Maragos

  • Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

    Mark J. Ferris;Charles F. Mactutus;Rosemarie M. Booze

  • Automation of the novel object recognition task for use in adolescent rats.

    Janelle M. Silvers;Steven B. Harrod;Charles F. Mactutus;Rosemarie M. Booze

  • Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor.

    Michael Y. Aksenov;Marina V. Aksenova;Avindra Nath;Philip D. Ray

  • Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine

    Jadwiga Turchan;Caroline Anderson;Kurt F Hauser;Qinmiao Sun

  • Cholinergic and gabaergic neurons in the nucleus basalis region of young and aged rats

    M.L. Smith;R.M. Booze

  • Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum.

    Michael Y. Aksenov;Ulla Hasselrot;Arvind K. Bansal;Guanghan Wu

  • Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats.

    R.M. Booze;A.F. Lehner;D.R. Wallace;M.A. Welch

  • Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function.

    David R. Wallace;Stephanie Dodson;Avindra Nath;Rosemarie M. Booze

  • HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [3H]Dopamine Uptake: Dissociation of [3H]Dopamine Uptake and [3H]2β-Carbomethoxy-3-β-(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes

    Jun Zhu;Charles F. Mactutus;David R. Wallace;Rosemarie M. Booze

  • Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones.

    Rosemarie M Booze;Marian A Welch;Marcie L Wood;Katharyn A Billings

  • Expression of insulin-like growth factor-1 (IGF-1) and IGF-binding protein 2 (IGF-BP2) in the hippocampus following cytotoxic lesion of the dentate gyrus.

    Charles R. Breese;Anselm D'Costa;Yvonne D. Rollins;Cathy Adams

  • Cell culture models of oxidative stress and injury in the central nervous system.

    Marina V. Aksenova;Michael Y. Aksenov;Charles F. Mactutus;Rosemarie M. Booze

  • Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum

    Michael Y Aksenov;Ulla Hasselrot;Guanghan Wu;Avindra Nath

  • Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors.

    Steven B Harrod;Charles F Mactutus;Klark Bennett;Ulla Hasselrot

  • Prenatal cocaine exposure impairs selective attention: Evidence from serial reversal and extradimensional shift tasks

    H. Garavan;R. E. Morgan;C. F. Mactutus;D. A. Levitsky

  • Chronic intravenous model for studies of drug (Ab)use in the pregnant and/or group-housed rat: an initial study with cocaine.

    Charles F. Mactutus;Alissa S. Herman;Rosemarie M. Booze

Frequent Co-Authors

Charles F. Mactutus
Charles F. Mactutus University of South Carolina
Barbara J. Strupp
Barbara J. Strupp Cornell University
Avindra Nath
Avindra Nath National Institutes of Health
Louis B. Hersh
Louis B. Hersh University of Kentucky
Jim R. Fadel
Jim R. Fadel University of South Carolina
James N. Davis
James N. Davis Duke University
Hugh Garavan
Hugh Garavan University of Vermont
Mark P. Mattson
Mark P. Mattson Johns Hopkins University
Wayne A. Cass
Wayne A. Cass University of Kentucky
Kamel Khalili
Kamel Khalili Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Rosemarie M. Booze

Trending Scientists

Recently Published Articles